PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

40,208 stories, page 370 of 671

Advanced search
🌍Researchdoi.orgTier 1 · Research record

AI Automation of Statistical Analysis Plans in Clinical Trials

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Improving Hospital Process Management Through Process Mining: A Case Study on COVID-19 Clinical Pathways

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Pills and Perspectives: Decoding Stance on Drug Use with the Rxtance Dataset

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Clinical Impact of Gleason Pattern 5 on Doublet Versus Triplet Therapy in Metastatic Hormone‐Sensitive Prostate Cancer

CrossrefOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Does Retatrutide Cause Erectile Dysfunction? - View OoaJqO0Si

FC BayernOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Jinghua Pharmaceutical Group Co., Ltd. Class A – SZSE:002349

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FSS moves to end inflated biotech tech-transfer disclosures

헤럴드경제Original source
🌍discoverynews.google.comTier 3 · Aggregated media

North Indias first Biotech Park at Kathua to emerge as hub of innovation, agri entrepreneurs: Dr Jitendra

Daily ExcelsiorOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

RTW Biotech Opportunities Ltd USD Revenue Breakdown – AQUISUK:RTWL

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Fda Approval Of Glp 1 Medications: The Ultimate Guide To Regulatory Milestones And Clinical Impact [VZWtPYB6BTg]

as.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Does KB801’s Single-Patient Signal And S&P 400 Move Change The Bull Case For Krystal Biotech (KRYS)?

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

XLV vs. IBBQ: Is Broad Healthcare Exposure or Biotech Growth the Better ETF Buy?

The Motley FoolOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ono Pharmaceutical (TSE:4528) Stock Holds Appeal Despite Revenue Retreat

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Are Erectile Dysfunction Meds Express Scripts Plan Exclusion - View X3m0xLLZv

FC BayernOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ETFs Investing in Xiangxue Pharmaceutical Co., Ltd. Class A Stocks

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Novo Nordisk's Failed Heart Drug Trial Wipes Out $20.5 Billion in Market Value

ad-hoc-news.deOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

PanGen Biotech, Inc. Revenue Breakdown – KRX:222110

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Legend Biotech CEO Resigns, Merck Deletes Trial Hint, And FDA Clears Novel ADHD Drug

londoninsider.co.ukOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Kathua Biotech Park to drive innovation, jobs across North India: Jitendra Singh

The TribuneOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Trump Proposes Generic Drug Tariffs Effective 2028, Signaling Fresh Push to Reshore Pharmaceutical Production - GAAP Earnings Report

dars.gov.etOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Federal advisors move to expand access to six wellness peptides

AOL.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ember LifeSciences and Alfresa Corp to improve quality of pharmaceutical cold chain in Japan

BioSpectrum AsiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

XLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist?

The Motley FoolOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical pollution needs to be stopped

thefinancialexpress.com.bdOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

XLV vs PBE: Healthcare Sector Stability vs Biotech Growth

sekbernews.idOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Anlon Healthcare Achieves Triple-Digit Growth in Q1 FY27, Strengthens Integrated Pharma Platform

India's News.NetOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

New HIV pill shows promise in first human safety trial

newskarnataka.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Collegium Pharmaceutical: Pain Cash Flows Are Funding An ADHD Re-Rating (NASDAQ:COLL)

Seeking AlphaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

IBA, Beximco launch first executive prog for pharma professionals

daily-sun.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

6 Reasons Pharma Manufacturing Has Eyes On Puerto Rico

Pharmaceutical OnlineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Heart Drug Recall: FDA Says More Than 5,000 Scripts Removed

The Healthy @Reader's DigestOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

MoU Signed to Operationalise North India’s First Industrial Biotech Park in Kathua; Dr Jitendra Singh Calls it a Major Boost for J&K’s Biotechnology Ecosystem

thepublicworld.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Concord Biotech: Q1 FY27 Revenue Jumps 26% to ₹257.5 Crore

InvestyWiseOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical Safety Review 2026 Exposes Why Pills To Lose Weight Rarely Deliver Lasting Results [SAwa8ztf72m]

Diario ASOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Bharat Biotech MD calls on students to contribute meaningfully to society

The HinduOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

A new ADHD drug just got FDA approval. Here's what makes it different.

AOL.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The 5 Most Interesting Analyst Questions From West Pharmaceutical Services’s Q2 Earnings Call

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Dr Reddy’s wins FDA nod for rituximab biosimilar

ET PharmaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Preoperative Dual Immunotherapy Shows Promise in High-Risk Early HER2-Negative Breast Cancer

Bioengineer.orgOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Apnimed Plans IPO to Raise $150 Million for Sleep Apnea Drug

Intellectia AIOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pfizer’s LITFULO clears two Phase 3 vitiligo trials paving way for global regulatory filings

Indian Pharma PostOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Novo Nordisk's Phase 3 ZEUS trial misses cardiovascular endpoint for Ziltivekimab

Indian Pharma PostOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

How Should Clinicians Weigh Kidney Cancer Data From ASCO 2026?

CancerNetworkOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

North China Pharmaceutical Company Ltd. Class A Revenue Breakdown – SSE:600812

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Redefining HIV Management: Emerging Antiretroviral Drug Classes and Immunologic Strategies Shaping the Future of HIV Treatment, Prevention

Contagion LiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Kathua Biotech Park to Drive Innovation & Jobs in J&K, North India

Rediff MoneyWizOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Concord Biotech Q1 Results: Net profit rises 31% YoY to ₹57.7 crore

scanx.tradeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO Revenue Breakdown – OTC:SKBHF

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Greater Philadelphia – Regional Life Sciences Roundup – July 31, 2026

BioBuzzOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Exposing The Most Dangerous Celebrity Skincare Launches Food (ej86YVXAPF)

MshaleOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The Third Dimension of Antibody Therapy

BioSpectrum AsiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Novo Nordisk's Failed Heart Drug Trial Deepens a Season of Setbacks

ad-hoc-news.deOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Concord Biotech shareholders approve enhanced loan limits at AGM

scanx.tradeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Bremelanotide Erectile Dysfunction Men Clinical Trial: What The Data Shows For Mens Sexual Health [c4FfBikXfav]

Diario ASOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech International Limited Reports Strong FY2025 Performance

indiasnews.netOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Yemeni Honey: From Natural Resource to Promising Pillar for Pharmaceutical Industry

saba.yeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Karnataka to ban junk food around schools

The New Indian ExpressOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

North Indias First Industrial Biotech Park At Kathua To Drive J&Ks Biotechnology Revolution: Dr Jitendra

Daily ExcelsiorOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

North India’s First Biotech Park At Kathua, A Hub Of Biotech Driven Entrepreneurship In The Region: Dr. Jitendra

Daily ExcelsiorOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Kolmar BioTech. Inc. – KRX:215380

TradingViewOriginal source